BioLargo, Inc.: Good News- Clyra Medical Receives FDA Clearance

BioLargo, Inc. (OTCQB:BLGO) is a cleantech and life sciences innovator and engineering services solution provider. Our core products address PFAS contamination, achieve advanced water and wastewater treatment, control odor and VOCs, improve air quality, and control infections and infectious disease. Our approach is to invent or acquire novel technologies, develop them into product offerings, and extend their commercial reach through licensing and channel partnerships to maximize their impact.

Friday 20 September 2019

Good News- Clyra Medical Receives FDA Clearance

Great News!

Clyra received FDA 510(k) clearance today-

We wanted to get the news out quickly, and we will have a more comprehensive press release out Monday morning at market open.

#GoBioLargo #GoClyra #Thankful

Dennis P. Calvert

President & CEO

BioLargo, Inc.

Friday 20 September 2019

Good News- Clyra Medical Receives FDA Clearance

No comments:

Post a Comment